top of page

Ocrevus (ocrelizumab)

Initial dose: 300 mg intravenous infusion, followed two weeks later by a second 300 mg intravenous infusion. Subsequent doses: single 600 mg intravenous infusion every 6 months.

Ocrevus (ocrelizumab)

LSG Infusion Services

Outpatient Infusion Services

349 East Northfield Road

Suite 200

Livingston, NJ 07039

Telephone: 973-597-0900

Fax: 973-597-0910

Serving Greater New York Metropolitan Area

Infusion Hours by Appointment: To schedule a patient, contact our "Infusion Care Coordinator".

bottom of page